Serum sodium and chloride are inversely associated with dyskinesia in Parkinson's disease patients
Authors:
Open Access
- 9 November 2017
- journal article
- research article
- Published by Wiley in Brain and Behavior
- Vol. 7 (12) , e00867
Abstract
Objective: We aim to report and evaluate the associations between serum sodium and chloride and dyskinesia in patients with Parkinson's disease. One hundred and two patients with Parkinson's disease were enrolled in this study.Methods: Patients’ serum electrolytes including sodium, calcium, potassium, magnesium, and chloride were measured. Other demographic information was collected, and Unified Parkinson's disease rating scale and Hoehn and Yahr stage scale were also performed.Results: Patients with dyskinesia tended to have longer duration of disease, higher daily levodopa‐equivalent dose, and Hoehn–Yahr stage, with lower serum sodium than those without dyskinesia. Spearman correlation analyses showed that serum sodium inversely correlated with duration of disease (r = −.218, p = .028), and positively correlated with serum chloride levels (r = .565, p < .001). Univariate logistic regression analysis found that duration of disease, daily levodopa‐equivalent dose, serum sodium, and serum chloride were associated with dyskinesia in Parkinson's disease patients (p < .05 for all). After adjusting for age, sex, age at onset of Parkinson's disease, medical history, and other covariates, serum sodium and chloride were still associated with dyskinesia, with corresponding Odd ratios 0.783 (95% confidence intervals, 0.642–0.955) and 0.796 (95% confidence intervals, 0.652–0.972), respectively.Conclusion: Our findings indicated that serum sodium and chloride levels were inversely associated with dyskinesia in patients with Parkinson's disease. Further studies with large samples and range of serum sodium and chloride are needed.Keywords
Funding Information
- National Key R&D Program of China (2017YFC0909100)
- Jiangsu Provincial Special Program of Medical Science (BL2014042)
- Jiangsu Province’s Young Medical Talents Program (QNRC2016872)
- Social development projects in Jiangsu Province (BE2017653)
- Suzhou Clinical Research Center of Neurological Disease (Szzx201503)
- Suzhou Science and Technology Development Program (SYS201620, SYS201624)
- Jiangsu Provincial Medical Key Discipline Project (ZDXKB2016022)
- Youth fund of Jiangsu Province’s natural science foundation (BK20170355)
- National Natural Science Pre-Research Foundation of China (SDFEYGJ1605)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 32 references indexed in Scilit:
- Selective Inhibition of Striatal Fast-Spiking Interneurons Causes DyskinesiasThe Journal of Neuroscience, 2011
- Astrocytes Are an Early Target in Osmotic Demyelination SyndromeJournal of the American Society of Nephrology, 2011
- Age of Parkinson's disease onset as a predictor for the development of dyskinesiaMovement Disorders, 2010
- Bench-to-bedside review: Chloride in critical illnessCritical Care, 2010
- Synaptic recruitment of AMPA glutamate receptor subunits in levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primateSynapse, 2009
- Calcium Homeostasis Is Dysregulated in Parkinsonian Patients With l-DOPA-Induced DyskinesiasClinical Neuropharmacology, 2009
- Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestationsMovement Disorders, 2005
- Levodopa‐dyskinesia incidence by age of Parkinson's disease onsetMovement Disorders, 2005
- HyponatremiaNew England Journal of Medicine, 2000
- ParkinsonismNeurology, 1967